Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 70/100 | DilutionWatch score record |
| Shares Outstanding | 2.37M | Verified float table or market cache |
| Public Float | Not available | Verified float table or market cache |
| Market Cap | $734.6K | Market data cache |
| Cash Runway | 11.2 months | DilutionWatch score inputs |
| Shelf Capacity | None in current score inputs | SEC-derived dilution fields |
| ATM Capacity | None in current score inputs | SEC-derived dilution fields |
| Outstanding Warrants | None in current score inputs | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 6.
Recent SEC source mix: 424B3 1, EFFECT 1, SC 13G 3, XBRL 1.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
LABT SEC Filing Activity — Last 12 Months
Shares outstanding reported by LABT on the cover page of its latest 10-K/10-Q: 2.37M as of August 03, 2026.
DilutionWatch recorded 1 registration or prospectus document for LABT (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →
| Form | What it is | Filings | Most recent |
|---|---|---|---|
| S-1 | registration statement (IPO / follow-on) | 1 | Sep 18, 2026 |
| EFFECT | SEC declared a registration effective | 1 | Sep 25, 2026 |
| DEF 14A | proxy statement | 1 | Aug 10, 2026 |
| SC 13G | passive >5% holder filing | 1 | Aug 06, 2026 |
Institutional Holdings
Short Interest
Recent SEC Activity
Recent News
Factual LABT Dilution Snapshot
Lakewood-Amedex Biotherapeutics Inc. (LABT) has a DilutionScore of 70/100, rated High dilution risk. Score date: October 24, 2026.
- Recent SEC activity tracked for LABT: EFFECT on 2026-09-24; xbrl on 2026-09-18; SC 13G on 2026-08-14.
- Score coverage note: Float Risk is excluded because public-float data is unavailable.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
LABT's DilutionScore is currently 70/100 (High risk), with 2 score changes tracked over 89 days. The score improved from 61/100 (High risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Oct 01 – Oct 24, 2026 | 70/100 | HIGH | 24 days |
| Aug 22 – Sep 30, 2026 | 61/100 | HIGH | 40 days |
| Jul 27 – Aug 21, 2026 | 56/100 | HIGH | 25 days |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.